{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:05:59Z","timestamp":1703203559357},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-023-04308-w","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T10:05:48Z","timestamp":1674554748000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of endoscopic retrograde cholangiopancreatography in patients with inflammatory bowel disease: a nationwide study"],"prefix":"10.1007","volume":"38","author":[{"given":"Markos","family":"Kalligeros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Kr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Desalermos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"4308_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11894-009-0073-8","volume":"11","author":"MH Vatn","year":"2009","unstructured":"Vatn MH (2009) Natural history and complications of IBD. Curr Gastroenterol Rep 11:481. https:\/\/doi.org\/10.1007\/s11894-009-0073-8","journal-title":"Curr Gastroenterol Rep"},{"key":"4308_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","volume":"14","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M et al (2016) Biologic Therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol 14:1385-1397.e1310. https:\/\/doi.org\/10.1016\/j.cgh.2016.04.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4308_CR3","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","volume":"11","author":"S Danese","year":"2005","unstructured":"Danese S, Semeraro S, Papa A et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11:7227\u20137236. https:\/\/doi.org\/10.3748\/wjg.v11.i46.7227","journal-title":"World J Gastroenterol"},{"key":"4308_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/flgastro-2018-101037","volume":"10","author":"A Yaccob","year":"2019","unstructured":"Yaccob A, Mari A (2019) Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease. Frontline Gastroenterology 10:309\u2013315. https:\/\/doi.org\/10.1136\/flgastro-2018-101037","journal-title":"Frontline Gastroenterology"},{"key":"4308_CR5","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ibd.21219","volume":"16","author":"U Navaneethan","year":"2010","unstructured":"Navaneethan U, Shen B (2010) Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 16:1598\u20131619. https:\/\/doi.org\/10.1002\/ibd.21219","journal-title":"Inflamm Bowel Dis"},{"key":"4308_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.12794","volume":"40","author":"E Gizard","year":"2014","unstructured":"Gizard E, Ford AC, Bronowicki J-P et al (2014) Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther 40:3\u201315. https:\/\/doi.org\/10.1111\/apt.12794","journal-title":"Aliment Pharmacol Ther"},{"key":"4308_CR7","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","volume":"161","author":"B Barberio","year":"2021","unstructured":"Barberio B, Massimi D, Cazzagon N et al (2021) Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis. Gastroenterology 161:1865\u20131877. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.032","journal-title":"Gastroenterology"},{"key":"4308_CR8","doi-asserted-by":"publisher","first-page":"E261","DOI":"10.1055\/s-0043-102402","volume":"5","author":"M Ahmed","year":"2017","unstructured":"Ahmed M, Kanotra R, Savani GT et al (2017) Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a cross-sectional US experience. Endosc Int Open 5:E261-e271. https:\/\/doi.org\/10.1055\/s-0043-102402","journal-title":"Endosc Int Open"},{"key":"4308_CR9","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00464-007-9711-0","volume":"22","author":"P Salminen","year":"2008","unstructured":"Salminen P, Laine S, Gullichsen R (2008) Severe and fatal complications after ERCP: analysis of 2555 procedures in a single experienced center. Surg Endosc 22:1965\u20131970. https:\/\/doi.org\/10.1007\/s00464-007-9711-0","journal-title":"Surg Endosc"},{"key":"4308_CR10","doi-asserted-by":"publisher","first-page":"E761","DOI":"10.1055\/a-1134-4873","volume":"8","author":"PT Kr\u00f6ner","year":"2020","unstructured":"Kr\u00f6ner PT, Bilal M, Samuel R et al (2020) Use of ERCP in the United States over the past decade. Endosc Int Open 8:E761-e769. https:\/\/doi.org\/10.1055\/a-1134-4873","journal-title":"Endosc Int Open"},{"key":"4308_CR11","unstructured":"(HCUP) HNISNHCaUP. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov\/nisoverview.jsp 2018\u20132019"},{"key":"4308_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"4308_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/1751-2980.12788","volume":"20","author":"JB Maurice","year":"2019","unstructured":"Maurice JB, Thorburn D (2019) Precision medicine in primary sclerosing cholangitis. J Dig Dis 20:346\u2013356. https:\/\/doi.org\/10.1111\/1751-2980.12788","journal-title":"J Dig Dis"},{"key":"4308_CR14","first-page":"1","volume":"8","author":"M Asfari","year":"2022","unstructured":"Asfari M (2022) Measure twice, cut once: appraising the safe-ty of ERCP in IBD. Japanese J Gstro Hepato 8:1\u20136","journal-title":"Japanese J Gstro Hepato"},{"key":"4308_CR15","doi-asserted-by":"publisher","first-page":"E1165","DOI":"10.1055\/a-1194-4049","volume":"8","author":"DA Farina","year":"2020","unstructured":"Farina DA, Komanduri S, Aadam AA et al (2020) Endoscopic retrograde cholangiopancreatography (ERCP) in critically ill patients is safe and effective when performed in the endoscopy suite. Endosc Int Open 8:E1165-e1172. https:\/\/doi.org\/10.1055\/a-1194-4049","journal-title":"Endosc Int Open"},{"key":"4308_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/archsurg.142.5.448","volume":"142","author":"J Fatima","year":"2007","unstructured":"Fatima J, Baron TH, Topazian MD et al (2007) Pancreaticobiliary and duodenal perforations after periampullary endoscopic procedures: diagnosis and management. Arch Surg 142:448\u2013455. https:\/\/doi.org\/10.1001\/archsurg.142.5.448","journal-title":"Arch Surg"},{"key":"4308_CR17","doi-asserted-by":"publisher","first-page":"13153","DOI":"10.3748\/wjg.v20.i36.13153","volume":"20","author":"M Pavlides","year":"2014","unstructured":"Pavlides M, Barnabas A, Fernandopulle N et al (2014) Repeat endoscopic retrograde cholangiopancreaticography after failed initial precut sphincterotomy for biliary cannulation. World J Gastroenterol 20:13153\u201313158. https:\/\/doi.org\/10.3748\/wjg.v20.i36.13153","journal-title":"World J Gastroenterol"},{"key":"4308_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.hbpd.2018.01.008","volume":"17","author":"ET Pavlidis","year":"2018","unstructured":"Pavlidis ET, Pavlidis TE (2018) Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int 17:17\u201321. https:\/\/doi.org\/10.1016\/j.hbpd.2018.01.008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"4308_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/aco.0000000000000163","volume":"28","author":"J Simmons","year":"2015","unstructured":"Simmons J, Pittet JF (2015) The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 28:227\u2013236. https:\/\/doi.org\/10.1097\/aco.0000000000000163","journal-title":"Curr Opin Anaesthesiol"},{"key":"4308_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.gie.2005.05.016","volume":"64","author":"S Varadarajulu","year":"2006","unstructured":"Varadarajulu S, Kilgore ML, Wilcox CM et al (2006) Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 64:338\u2013347. https:\/\/doi.org\/10.1016\/j.gie.2005.05.016","journal-title":"Gastrointest Endosc"},{"key":"4308_CR21","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/asn.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, Burdick E, Honour M et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365\u20133370. https:\/\/doi.org\/10.1681\/asn.2004090740","journal-title":"J Am Soc Nephrol"},{"key":"4308_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jcrc.2009.09.001","volume":"25","author":"Y Yang","year":"2010","unstructured":"Yang Y, Yang KS, Hsann YM et al (2010) The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis. J Crit Care 25:398\u2013405. https:\/\/doi.org\/10.1016\/j.jcrc.2009.09.001","journal-title":"J Crit Care"},{"key":"4308_CR23","doi-asserted-by":"publisher","unstructured":"Benchimol EI, Smeeth L, Guttmann A et al (2015) The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 12:e1001885.\u00a0https:\/\/doi.org\/10.1371\/journal.pmed.1001885","DOI":"10.1371\/journal.pmed.1001885"},{"key":"4308_CR24","doi-asserted-by":"publisher","first-page":"E272","DOI":"10.1055\/s-0043-101697","volume":"5","author":"RA Kozarek","year":"2017","unstructured":"Kozarek RA (2017) The future of ERCP. Endosc Int Open 5:E272-e274. https:\/\/doi.org\/10.1055\/s-0043-101697","journal-title":"Endosc Int Open"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-023-04308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:07:58Z","timestamp":1703156878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-023-04308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1007\/s00384-023-04308-w","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"1 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None. This study was retrospective review of publicly available database. No IRB approval or patient consent were obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"M.K., P.T.K., and A.D. declare that they have no potential conflict of interest. F.A.F. is a consultant for BMS, Braintree labs, GSK, Innovation Pharmaceuticals, Iterative Scopes, Janssen, Pfizer, and Sebela and sits on a DSMB for Lilly and Theravance.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"23"}}